DarioHealth Corp. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
DarioHealth Corp. (DRIO) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of $7.92 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2026-08-11
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2026-06-30 was $7.92B, a 39.00% decline year-over-year.
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2026-03-31 was $8.25B, a 10.60% decline year-over-year.
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2025-12-31 was $9.03M, a 6.24% decline year-over-year.
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2025-09-30 was $10.47M, a 15.12% decline year-over-year.
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2025 was $41.71M, a 2.42% decline from fiscal 2024.
- DarioHealth Corp. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2024 was $42.75M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.92B 10-Q · filed 2026-08-11 | $16.17B 10-Q · filed 2026-08-11 | $16.18B derived: sum of 3 quarters · filed 2026-08-11 | $16.19B derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $8.25B 10-Q · filed 2026-05-13 | $8.26B derived: sum of 2 quarters · filed 2026-05-13 | $8.27B derived: sum of 3 quarters · filed 2026-05-13 | $21.26B derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $19.50M derived: sum of 2 quarters · filed 2026-03-19 | $13.01B derived: sum of 3 quarters · filed 2026-08-11 | $41.71M 10-K · filed 2026-03-19 | ||
| 2025-09-30 | $10.47M 10-Q · filed 2025-11-13 | $13.00B derived: sum of 2 quarters · filed 2026-08-11 | $32.68M 10-Q · filed 2025-11-13 | $22.24B derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $12.99B 10-Q · filed 2026-08-11 | $12.99M 10-Q · filed 2025-08-12 | $22.22B 10-Q · filed 2026-08-11 | $22.22M 10-Q · filed 2025-08-12 | $22.23B derived: sum of 3 quarters · filed 2026-08-11 | $22.24B derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $9.23B 10-Q · filed 2026-05-13 | $9.24B derived: sum of 2 quarters · filed 2026-05-13 | $9.25B derived: sum of 3 quarters · filed 2026-05-13 | $9.26B derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $9.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $21.96M derived: sum of 2 quarters · filed 2026-03-19 | $35.57M derived: sum of 3 quarters · filed 2026-03-19 | $42.75M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | $12.33M 10-Q · filed 2025-11-13 | $25.94M derived: sum of 2 quarters · filed 2025-11-13 | $33.12M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $13.61M 10-Q · filed 2025-08-12 | $20.78M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |